IL-2 has shown promise for the treatment of a number of cancer types (melanoma, renal cell carcinoma, hepatocellular carcinoma, mesothelioma, ovarian cancer, gastrointestinal cancer, lung cancer, and basal cell carcinoma) [23,24,54]. Here, IL2 is linked to hereditary clear cell renal cell carcinoma.